Thailand's new government will review its predecessor's decision to ignore patents on several cancer-fighting drugs, a move that allowed cheaper generic versions to be imported and manufactured, a government statement said Saturday.
On Jan. 4, less than a month before leaving office, the government of former Prime Minister Surayud Chulanont issued so-called "compulsory licenses" for four anti-cancer drugs, effectively depriving the drugs' license holders of patent protection in Thailand.
The object of compulsory licensing was to make some drugs more affordable by taking away the patent holder's ability to control the drug's price, a benefit of …
No comments:
Post a Comment